These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 28756637

  • 1. Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.
    Ra SW, Kwon YS, Yoon SH, Jung CY, Kim J, Choi HS, Sheen SS, Hwang HG, Lee JH, Kim TH.
    Clin Respir J; 2018 Apr; 12(4):1424-1432. PubMed ID: 28756637
    [Abstract] [Full Text] [Related]

  • 2. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
    Soler N, Agustí C, Angrill J, Puig De la Bellacasa J, Torres A.
    Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
    [Abstract] [Full Text] [Related]

  • 3. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH, Kuo PH, Hsueh PR, Yang PC, Kuo SH.
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [Abstract] [Full Text] [Related]

  • 4. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C, Tian C, Zhang Y, Yang X, Feng Y, Fan H.
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
    Malvisi L, Taddei L, Yarraguntla A, Wilkinson TMA, Arora AK, AERIS Study Group.
    Respir Res; 2021 Feb 24; 22(1):67. PubMed ID: 33627095
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2015 Feb 24; 10():985-93. PubMed ID: 26082623
    [Abstract] [Full Text] [Related]

  • 8. Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
    Sethi S, Anzueto A, Miravitlles M, Arvis P, Alder J, Haverstock D, Trajanovic M, Wilson R.
    Infection; 2016 Feb 24; 44(1):65-76. PubMed ID: 26370552
    [Abstract] [Full Text] [Related]

  • 9. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E, Groenhof F, Hendrix R, van der Molen T, Sinha B, Kerstjens HA, Friedrich AW, Kocks JW.
    Int J Chron Obstruct Pulmon Dis; 2017 Feb 24; 12():285-290. PubMed ID: 28144133
    [Abstract] [Full Text] [Related]

  • 10. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study.
    Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Duval V, De Champs C, Lebargy F, Andreoletti L.
    J Med Virol; 2013 May 24; 85(5):866-73. PubMed ID: 23447038
    [Abstract] [Full Text] [Related]

  • 11. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
    Sethi S, Evans N, Grant BJ, Murphy TF.
    N Engl J Med; 2002 Aug 15; 347(7):465-71. PubMed ID: 12181400
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.
    Larsen MV, Janner JH, Nielsen SD, Friis-Møller A, Ringbaek T, Lange P.
    Scand J Infect Dis; 2009 Aug 15; 41(1):26-32. PubMed ID: 18855228
    [Abstract] [Full Text] [Related]

  • 14. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.
    Ko FW, Ng TK, Li TS, Fok JP, Chan MC, Wu AK, Hui DS.
    Respir Med; 2005 Apr 15; 99(4):454-60. PubMed ID: 15763452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
    Alamoudi OS.
    Respirology; 2007 Mar 15; 12(2):283-7. PubMed ID: 17298464
    [Abstract] [Full Text] [Related]

  • 17. [Bacteriology of acute exacerbations of chronic obstructive pulmonary disease in Tunisia].
    Messous S, Grissa MH, Beltaief K, Boukef R, Nouira S, Mastouri M.
    Rev Mal Respir; 2018 Jan 15; 35(1):36-47. PubMed ID: 29395563
    [Abstract] [Full Text] [Related]

  • 18. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
    Soler N, Esperatti M, Ewig S, Huerta A, Agustí C, Torres A.
    Eur Respir J; 2012 Dec 15; 40(6):1344-53. PubMed ID: 22523352
    [Abstract] [Full Text] [Related]

  • 19. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A.
    Arch Intern Med; 2005 Apr 25; 165(8):891-7. PubMed ID: 15851640
    [Abstract] [Full Text] [Related]

  • 20. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
    Tsimogianni AM, Papiris SA, Kanavaki S, Stathopoulos GT, Sotiropoulou C, Manali ED, Michalopoulou P, Roussos C, Kotanidou A.
    Respirology; 2009 Nov 25; 14(8):1114-20. PubMed ID: 19761538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.